GB1269775A - Alkanolamine derivatives - Google Patents
Alkanolamine derivativesInfo
- Publication number
- GB1269775A GB1269775A GB34255/68A GB3425568A GB1269775A GB 1269775 A GB1269775 A GB 1269775A GB 34255/68 A GB34255/68 A GB 34255/68A GB 3425568 A GB3425568 A GB 3425568A GB 1269775 A GB1269775 A GB 1269775A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- aryl
- substituted
- cycloalkyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 abstract 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 abstract 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 abstract 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- 241000208011 Digitalis Species 0.000 abstract 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 abstract 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 abstract 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 abstract 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 abstract 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 abstract 1
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical compound C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 230000001800 adrenalinergic effect Effects 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 229960004980 betanidine Drugs 0.000 abstract 1
- NIVZHWNOUVJHKV-UHFFFAOYSA-N bethanidine Chemical compound CN\C(=N/C)NCC1=CC=CC=C1 NIVZHWNOUVJHKV-UHFFFAOYSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000000168 bronchodilator agent Substances 0.000 abstract 1
- 239000000496 cardiotonic agent Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960002155 chlorothiazide Drugs 0.000 abstract 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001076 chlorpromazine Drugs 0.000 abstract 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 229960003711 glyceryl trinitrate Drugs 0.000 abstract 1
- 229960003602 guanethidine Drugs 0.000 abstract 1
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 229960001317 isoprenaline Drugs 0.000 abstract 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 abstract 1
- 229960000201 isosorbide dinitrate Drugs 0.000 abstract 1
- 229960004815 meprobamate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 or ciprenaline Chemical compound 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960002695 phenobarbital Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960001404 quinidine Drugs 0.000 abstract 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 abstract 1
- 229960003147 reserpine Drugs 0.000 abstract 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229960001032 trihexyphenidyl Drugs 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB34255/68A GB1269775A (en) | 1968-07-18 | 1968-07-18 | Alkanolamine derivatives |
| IE889/69A IE33184B1 (en) | 1968-07-18 | 1969-06-30 | Alkanolamine derivatives |
| ZA694631*A ZA694631B (en) | 1968-07-18 | 1969-06-30 | Alkanolamine derivatives |
| PL1969134576A PL80101B1 (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-02 | |
| US839810A US3676493A (en) | 1968-07-18 | 1969-07-03 | Alkanolamine derivatives |
| IL32640A IL32640A (en) | 1968-07-18 | 1969-07-16 | 3-carbamoylphenoxy-1-amino-2-propanol derivatives |
| NL6910914A NL6910914A (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-16 | |
| SE6910133A SE379536B (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-17 | |
| ES369624A ES369624A1 (es) | 1968-07-18 | 1969-07-17 | Procedimiento para la produccion de derivados de alcanola- mina. |
| NO2987/69A NO125445B (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-17 | |
| BR210824/69A BR6910824D0 (pt) | 1968-07-18 | 1969-07-17 | Derivados de alcanolaminas |
| BE736231D BE736231A (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-17 | |
| CH1104269A CH520103A (de) | 1968-07-18 | 1969-07-18 | Verfahren zur Herstellung von Alkanolaminderivaten |
| AT692769A AT296256B (de) | 1968-07-18 | 1969-07-18 | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen und von deren Säureadditionssalzen |
| JP44056976A JPS4842869B1 (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-18 | |
| CH213472A CH533596A (de) | 1968-07-18 | 1969-07-18 | Verfahren zur Herstellung von Alkanolaminderivaten |
| AT1059870A AT299914B (de) | 1968-07-18 | 1969-07-18 | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen |
| FR6924615A FR2013209A1 (enrdf_load_stackoverflow) | 1968-07-18 | 1969-07-18 | |
| CH213372A CH539018A (de) | 1968-07-18 | 1969-07-18 | Verfahren zur Herstellung von Alkanolaminderivaten |
| DE19691936693 DE1936693A1 (de) | 1968-07-18 | 1969-07-18 | Alkanolamin dervate und Verfahren zu deren Herstellung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB34255/68A GB1269775A (en) | 1968-07-18 | 1968-07-18 | Alkanolamine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1269775A true GB1269775A (en) | 1972-04-06 |
Family
ID=10363358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB34255/68A Expired GB1269775A (en) | 1968-07-18 | 1968-07-18 | Alkanolamine derivatives |
Country Status (16)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5231858B1 (enrdf_load_stackoverflow) * | 1969-12-17 | 1977-08-17 | ||
| GB1312055A (en) * | 1970-04-20 | 1973-04-04 | Ici Ltd | Alkanolamine derivatives |
| DE2324176A1 (de) * | 1973-05-12 | 1974-11-28 | Bayer Ag | Neue katalysatoren und ihre verwendung bei der herstellung von polyurethanen |
| GB1460593A (en) * | 1973-06-22 | 1977-01-06 | Ici Ltd | Ethanolamine derivatives |
| GB1413911A (en) * | 1973-08-18 | 1975-11-12 | Pfizer Ltd | Preparation of propanolamine derivatives |
| FI65987C (fi) * | 1973-12-12 | 1984-08-10 | Ici Ltd | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat |
| US4165384A (en) * | 1974-11-01 | 1979-08-21 | Aktiebolaget Hassle | Amide substituted phenoxy propanol amines |
| US4145443A (en) * | 1977-10-31 | 1979-03-20 | Syntex (U.S.A.) Inc. | Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents |
| US4151297A (en) * | 1977-10-31 | 1979-04-24 | Syntex (U.S.A.) Inc. | Bicyclo [3.1.0] hexyl-substituted ethylamino carbonyl phenoxy cardiovascular agents |
| US4163053A (en) * | 1977-12-27 | 1979-07-31 | Schering Corporation | Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides |
| US4428883A (en) | 1981-03-06 | 1984-01-31 | The University Of Kentucky Research Foundation | Novel method of administering β-blockers and novel dosage forms containing same |
| JPS58109461A (ja) * | 1981-12-24 | 1983-06-29 | Kowa Co | 新規ベンズアミド誘導体 |
| US4503075A (en) * | 1982-11-12 | 1985-03-05 | A. Menarini S.A.S. | Derivatives of 1-alkylamine-3[4(p-alkyloxy-benzamide)phenoxy]-2-propanol, having beta-sympatholytic activity, their salts, and production processes thereof |
| FR2607812B1 (fr) * | 1986-12-05 | 1989-04-07 | Roussel Uclaf | Nouveaux derives du benzamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| WO1993012069A1 (en) * | 1991-12-16 | 1993-06-24 | Yamanouchi Pharmaceutical Co., Ltd. | Novel amino alcohol derivative or salt thereof |
| US6951962B2 (en) * | 2002-04-12 | 2005-10-04 | Hercules Incorporated | Oil/grease- and water-sizing agent for treatment of cellulosics |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE639158A (enrdf_load_stackoverflow) * | 1961-12-05 | |||
| GB1078852A (en) * | 1964-09-30 | 1967-08-09 | Ici Ltd | Alkanolamine derivatives |
-
1968
- 1968-07-18 GB GB34255/68A patent/GB1269775A/en not_active Expired
-
1969
- 1969-06-30 IE IE889/69A patent/IE33184B1/xx unknown
- 1969-06-30 ZA ZA694631*A patent/ZA694631B/xx unknown
- 1969-07-02 PL PL1969134576A patent/PL80101B1/pl unknown
- 1969-07-03 US US839810A patent/US3676493A/en not_active Expired - Lifetime
- 1969-07-16 IL IL32640A patent/IL32640A/xx unknown
- 1969-07-16 NL NL6910914A patent/NL6910914A/xx unknown
- 1969-07-17 BE BE736231D patent/BE736231A/xx unknown
- 1969-07-17 BR BR210824/69A patent/BR6910824D0/pt unknown
- 1969-07-17 NO NO2987/69A patent/NO125445B/no unknown
- 1969-07-17 ES ES369624A patent/ES369624A1/es not_active Expired
- 1969-07-18 FR FR6924615A patent/FR2013209A1/fr not_active Withdrawn
- 1969-07-18 AT AT1059870A patent/AT299914B/de not_active IP Right Cessation
- 1969-07-18 CH CH213372A patent/CH539018A/de not_active IP Right Cessation
- 1969-07-18 JP JP44056976A patent/JPS4842869B1/ja active Pending
- 1969-07-18 DE DE19691936693 patent/DE1936693A1/de active Pending
- 1969-07-18 CH CH1104269A patent/CH520103A/de not_active IP Right Cessation
- 1969-07-18 CH CH213472A patent/CH533596A/de not_active IP Right Cessation
- 1969-07-18 AT AT692769A patent/AT296256B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES369624A1 (es) | 1971-06-01 |
| FR2013209A1 (enrdf_load_stackoverflow) | 1970-03-27 |
| IE33184L (en) | 1970-01-18 |
| NL6910914A (enrdf_load_stackoverflow) | 1970-01-20 |
| AT299914B (de) | 1972-07-10 |
| IE33184B1 (en) | 1974-04-17 |
| BE736231A (enrdf_load_stackoverflow) | 1970-01-19 |
| BR6910824D0 (pt) | 1973-02-22 |
| ZA694631B (en) | 1971-02-24 |
| CH539018A (de) | 1973-08-31 |
| CH520103A (de) | 1972-03-15 |
| CH533596A (de) | 1973-02-15 |
| IL32640A (en) | 1975-06-25 |
| JPS4842869B1 (enrdf_load_stackoverflow) | 1973-12-14 |
| IL32640A0 (en) | 1969-11-12 |
| US3676493A (en) | 1972-07-11 |
| DE1936693A1 (de) | 1970-01-22 |
| PL80101B1 (enrdf_load_stackoverflow) | 1975-08-30 |
| AT296256B (de) | 1972-02-10 |
| NO125445B (enrdf_load_stackoverflow) | 1972-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1199037A (en) | Alkanolamine Derivatives | |
| GB1269775A (en) | Alkanolamine derivatives | |
| GB1460593A (en) | Ethanolamine derivatives | |
| GB1455116A (en) | Pharmaceutical compositions | |
| GB1199632A (en) | Alkanolamine Derivatives | |
| GB1260848A (en) | Propanolamine derivatives | |
| GB1460980A (en) | 3-substituted diphenylhydantoins | |
| GB1452701A (en) | Morpholine derivatives | |
| GB1269781A (en) | Alkanolamine derivatives | |
| GB1169945A (en) | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives | |
| GB1396322A (en) | Alkanolamine derivatives | |
| GB1387630A (en) | Phenoxyalkanolamine derivatives | |
| US3864390A (en) | 1-formylphenoxy-3-amino-2-propanol derivatives | |
| GB1415505A (en) | Alkanolamine derivatives | |
| GB1312055A (en) | Alkanolamine derivatives | |
| GB1393675A (en) | Alkanolamine derivatives | |
| JPS5212141A (en) | Novel amino benzoic acid derivatives, their preparation, and pharmaceu tical compositions therefrom | |
| GB1312555A (en) | Alkanolamine derivatives | |
| FR2429219A1 (fr) | Medicament a base de derives de la thienopyridone ou de la furopyridone | |
| GB1392610A (en) | Alkanolamine derivatives | |
| GB1077249A (en) | A new amine and process for its manufacture | |
| GB1414781A (en) | Alkanolamine derivatives | |
| GB1498083A (en) | Pharmaceutical preparations | |
| GB1193889A (en) | Dibenzo-Thiadiazoeines and the Manufacture Thereof | |
| IE31963L (en) | Pharmaceutical compositions |